The p38 mitogen-activated protein kinase pathway in interferon signal transduction

被引:70
作者
Katsoulidis, E
Li, YZ
Mears, H
Platanias, LC
机构
[1] Northwestern Univ, Sch Med, Robert H Luire Comprehens Canc Ctr, Chicago, IL 60611 USA
[2] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[3] Lakeside Vet Affairs Med Ctr, Chicago, IL 60611 USA
关键词
D O I
10.1089/jir.2005.25.749
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferons (IFNs) are cytokines that regulate a variety of biologic effects, including cellular antiviral responses, inhibition of proliferation, induction of differentiation, and immunoregulation, via different mechanisms. In order to mediate such pleiotropic effects, IFNs trigger numerous signaling events. One way for IFNs to regulate cellular functions is through activation of mitogen-activated protein ( MAP) kinases. Three major cascades of MAP kinases are known. The c-Jun NH2-terminal kinase ( JNK) cascade, the extracellular signal-regulated kinase ( ERK) cascade, and the p38 MAP kinase cascade. ERK and p38 MAP kinases are activated in response to type I IFNs and participate in the regulation of cellular responses. In this review we discuss recent findings on the role of the p38 MAP kinase pathway and its function in mediating IFN-dependent biologic effects. We further dissect and discuss the roles of upstream and downstream components of the p38 MAP kinase in the control of cellular responses triggered by IFNs.
引用
收藏
页码:749 / 756
页数:8
相关论文
共 83 条
[71]  
Uddin S, 2000, J BIOL CHEM, V275, P27634
[72]   Activation of the p38 mitogen-activated protein kinase by type I interferons [J].
Uddin, S ;
Majchrzak, B ;
Woodson, J ;
Arunkumar, P ;
Alsayed, Y ;
Pine, R ;
Young, PR ;
Fish, EN ;
Platanias, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30127-30131
[73]   Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells [J].
Uddin, S ;
Ah-Kang, J ;
Ulaszek, J ;
Mahmud, D ;
Wickrema, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (01) :147-152
[74]   The vav proto-oncogene product (p95(vav)) interacts with the Tyk-2 protein tyrosine kinase [J].
Uddin, S ;
Sweet, M ;
Colamonici, OR ;
Krolewski, JJ ;
Platanias, LC .
FEBS LETTERS, 1997, 403 (01) :31-34
[75]   Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock [J].
Uhlik, MT ;
Abell, AN ;
Johnson, NL ;
Sun, WY ;
Cuevas, BD ;
Lobel-Rice, KE ;
Horne, EA ;
Dell'Acqua, ML ;
Johnson, GL .
NATURE CELL BIOLOGY, 2003, 5 (12) :1104-1110
[76]   Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I Interferons and transforming growth factor-β on normal hematopoiesis [J].
Verma, A ;
Deb, DK ;
Sassano, A ;
Uddin, S ;
Varga, J ;
Wickrema, A ;
Platanias, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :7726-7735
[77]   Cutting edge: Activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia [J].
Verma, A ;
Deb, DK ;
Sassano, A ;
Kambhampati, S ;
Wickrema, A ;
Uddin, S ;
Mohindru, M ;
Van Besien, K ;
Platanias, LC .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :5984-5988
[78]   Mitogen-activated protein kinases in apoptosis regulation [J].
Wada, T ;
Penninger, JM .
ONCOGENE, 2004, 23 (16) :2838-2849
[79]   HDM2 phosphorylation by MAPKAP kinase 2 [J].
Weber, HO ;
Ludwig, RL ;
Morrison, D ;
Kotlyarov, A ;
Gaestel, M ;
Vousden, KH .
ONCOGENE, 2005, 24 (12) :1965-1972
[80]   The functional interactions between the p53 and MAPK signaling pathways [J].
Wu, GS .
CANCER BIOLOGY & THERAPY, 2004, 3 (02) :156-161